Webster Cabergoline Trial
1994
Cabergoline versus Bromocriptine in Hyperprolactinaemic Amenorrhoea
In 459 women with hyperprolactinaemic amenorrhoea, cabergoline 0.5–1.0 mg twice weekly achieved stable normoprolactinaemia, ovulation and pregnancy more often than bromocriptine.
Result
- Absolute difference
- 24 points
- NNT
- 5
Absolute difference and NNT are derived from the event rates.
Also reported: Ovulation/pregnancy 72 % vs 52 %; better tolerability.
- Subtopic
- Prolactinoma
- Design
- Double-blind RCT
- Relevance
- Supporting: context rather than must-know.
- Source
- Webster J, et al. N Engl J Med. 1994;331(14):904-909.doi 10.1056/NEJM199410063311403
Discussion & critique
Established cabergoline as first-line therapy for prolactinoma, a position unchanged for three decades.